Literature DB >> 24549317

Downregulation of Rap1 promotes 5-fluorouracil-induced apoptosis in hepatocellular carcinoma cell line HepG2.

Yong Zha1, Ping Gan1, Qian Yao2, Feng-Ming Ran3, Jing Tan1.   

Abstract

Recent studies have revealed that repressor/activator protein (Rap1) not only protects telomeres from sister chromatid exchange, but also functions in genomewide transcriptional regulation. Knockdown of Rap1 sensitizes breast cancer cells to adriamycin-induced apoptosis. However, little is known about the role of Rap1 in the progression of hepatocellular carcinoma (HCC). The present study aimed to investigate the functions of Rap1 in HCC progression and to determine whether targeting the Rap1 signaling pathway may be of therapeutic value against HCC. We found knockdown of Rap1 by microRNA (miRNA) interference enhanced significantly apoptosis and 5-fluorouracil (5-FU) chemosensitivity in HepG2 cell line. Rap1 miRNA downregulated nuclear factor-κB p65 (NF-κB p65) expression, and upregulated inhibitor of NF-κB (IκB) expression. In vivo, Rap1 miRNA combined with 5-FU treatment led to a significant reduction of tumor growth as compared with 5-FU alone. The results indicate that Rap1 miRNA can effectively enhance sensitivity of HepG2 cell line to 5-FU chemotherapy in vitro and in vivo.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24549317     DOI: 10.3892/or.2014.3033

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  11 in total

1.  Amyloid precursor protein regulates 5-fluorouracil resistance in human hepatocellular carcinoma cells by inhibiting the mitochondrial apoptotic pathway.

Authors:  Xiao-Long Wu; Ying Chen; Wen-Cui Kong; Zhong-Quan Zhao
Journal:  J Zhejiang Univ Sci B       Date:  2020 Mar.       Impact factor: 3.066

Review 2.  Data Centric Molecular Analysis and Evaluation of Hepatocellular Carcinoma Therapeutics Using Machine Intelligence-Based Tools.

Authors:  Rengul Cetin-Atalay; Deniz Cansen Kahraman; Esra Nalbat; Ahmet Sureyya Rifaioglu; Ahmet Atakan; Ataberk Donmez; Heval Atas; M Volkan Atalay; Aybar C Acar; Tunca Doğan
Journal:  J Gastrointest Cancer       Date:  2021-12-15

3.  Myosin phosphatase and RhoA-activated kinase modulate arginine methylation by the regulation of protein arginine methyltransferase 5 in hepatocellular carcinoma cells.

Authors:  Adrienn Sipos; Judit Iván; Bálint Bécsi; Zsuzsanna Darula; István Tamás; Dániel Horváth; Katalin F Medzihradszky; Ferenc Erdődi; Beáta Lontay
Journal:  Sci Rep       Date:  2017-01-11       Impact factor: 4.379

4.  Role of microRNAs in inflammation-associated liver cancer.

Authors:  Lin Huan; Lin-Hui Liang; Xiang-Huo He
Journal:  Cancer Biol Med       Date:  2016-12       Impact factor: 4.248

5.  Individualized predictive signatures for 5-fluorouracil-based chemotherapy in right- and left-sided colon cancer.

Authors:  Kai Song; Wenyuan Zhao; Wen Wang; Na Zhang; Kai Wang; Zhiqiang Chang
Journal:  Cancer Sci       Date:  2018-05-23       Impact factor: 6.716

6.  Telomere-dependent and telomere-independent roles of RAP1 in regulating human stem cell homeostasis.

Authors:  Xing Zhang; Zunpeng Liu; Xiaoqian Liu; Si Wang; Yiyuan Zhang; Xiaojuan He; Shuhui Sun; Shuai Ma; Ng Shyh-Chang; Feng Liu; Qiang Wang; Xiaoqun Wang; Lin Liu; Weiqi Zhang; Moshi Song; Guang-Hui Liu; Jing Qu
Journal:  Protein Cell       Date:  2019-02-22       Impact factor: 14.870

7.  MIR22HG As A Tumor Suppressive lncRNA In HCC: A Comprehensive Analysis Integrating RT-qPCR, mRNA-Seq, And Microarrays.

Authors:  Li Gao; Dan-Dan Xiong; Yi-Wu Dang; Gang Chen; Rong-Quan He; Xia Yang; Ze-Feng Lai; Li-Min Liu; Zhi-Guang Huang; Hua-Yu Wu; Li-Hua Yang; Jie Ma; Sheng-Hua Li; Peng Lin; Hong Yang; Dian-Zhong Luo
Journal:  Onco Targets Ther       Date:  2019-11-18       Impact factor: 4.147

8.  Multi-omics landscapes of colorectal cancer subtypes discriminated by an individualized prognostic signature for 5-fluorouracil-based chemotherapy.

Authors:  M Tong; W Zheng; H Li; X Li; L Ao; Y Shen; Q Liang; J Li; G Hong; H Yan; H Cai; M Li; Q Guan; Z Guo
Journal:  Oncogenesis       Date:  2016-07-18       Impact factor: 7.485

9.  LncRNA HOXA11-AS promotes hepatocellular carcinoma progression by repressing miR-214-3p.

Authors:  Meixiao Zhan; Ke He; Jing Xiao; Fei Liu; Haihe Wang; Zhenglin Xia; Xiaopeng Duan; Rui Huang; Yong Li; Xu He; Hua Yin; Guoan Xiang; Ligong Lu
Journal:  J Cell Mol Med       Date:  2018-05-15       Impact factor: 5.295

10.  Up-Regulation of hsa_circ_0000517 Predicts Adverse Prognosis of Hepatocellular Carcinoma.

Authors:  Xicheng Wang; Xining Wang; Wenxin Li; Qi Zhang; Jie Chen; Tao Chen
Journal:  Front Oncol       Date:  2019-10-22       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.